HR 5663 · 117th Congress 2021–2023, ended

TREAT Act

Introduced Oct 21, 2021 Originated House Sponsor Diana Harshbarger R-TN

Fact sheet Spreadsheet

Latest action · Oct 22, 2021 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedOct 21, 2021
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Treatment Restoration for Emergency Antibody Therapeutics Act or the TREAT Act

This bill prohibits the Department of Health and Human Services (HHS) from implementing any policy that restricts health care facilities from ordering and receiving COVID-19 monoclonal antibody therapies directly from manufacturers and distributors. In addition, the bill expressly nullifies a policy announced on September 13, 2021, under which HHS allocated supplies of these therapies through state or territorial governments.

Cosponsors 24

Members who signed on, in the order they did. Signatures ran from Oct 21, 2021 to Feb 2, 2022; 17 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-GAAustin ScottOriginalOct 21, 2021
R-FLBill PoseyOriginalOct 21, 2021
R-TXBrian BabinOriginalOct 21, 2021
R-FLBrian J. MastOriginalOct 21, 2021
R-FLByron DonaldsOriginalOct 21, 2021
R-TNCharles J. "Chuck" FleischmannOriginalOct 21, 2021
R-TXChip RoyOriginalOct 21, 2021
R-TNJohn W. RoseOriginalOct 21, 2021
R-FLKat CammackOriginalOct 21, 2021
R-TXLouie GohmertOriginalOct 21, 2021
R-IAMariannette Miller-MeeksOriginalOct 21, 2021
R-TXRoger WilliamsOriginalOct 21, 2021
R-TXRonny JacksonOriginalOct 21, 2021
R-TNScott DesJarlaisOriginalOct 21, 2021
R-PAScott PerryOriginalOct 21, 2021
R-TNTim BurchettOriginalOct 21, 2021
R-FLW. Gregory SteubeOriginalOct 21, 2021
R-ALBarry MooreOct 22, 2021
R-NYClaudia TenneyOct 28, 2021
R-COLauren BoebertNov 5, 2021
R-WIGlenn GrothmanJan 10, 2022
R-FLJohn H. RutherfordJan 11, 2022
R-LAJulia LetlowJan 13, 2022
R-TXPat FallonFeb 2, 2022

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Oct 21, 2021
Health Subcommittee
Referred Oct 22, 2021

Actions 3

Everything that happened, newest first.

  1. Oct 22, 2021Referred to the Subcommittee on Health.
  2. Oct 21, 2021Introduced in House
  3. Oct 21, 2021Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H182Glenn Grothman R-WIJan 13, 2022

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8 of the United States Constitution

The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 185, October 21, 2021, page H5792.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 2866TREAT ActIdentical billSep 28, 2021

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To prohibit the Secretary of Health and Human Services from restricting direct access by health care facilities to COVID-19 monoclonal antibody therapies.
Short Title(s) as Introduced
TREAT Act
Treatment Restoration for Emergency Antibody Therapeutics Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Oct 21, 2021Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.